Summary
The provided FDA-label excerpts do not contain information needed to verify the majority of the AI response claims (e.g., pricing, pharmacy/insurance availability, number of manufacturers, generic-market statements, and IV vs IM route). Only a small subset of claims maps to the supplied label text (e.g., indications for edema related to heart failure/cirrhosis/renal disease; contraindication in anuria; warning about excessive dosing causing water/electrolyte depletion; dehydration and electrolyte imbalance; monitoring). Most other claims are therefore unsupported or not assessable from the provided excerpts.
Category Scores
Accurate Statements
Furosemide injection is a loop diuretic.
Furosemide injection is FDA-approved.
Furosemide injection is a generic drug.
Furosemide is a loop diuretic.
Furosemide injection is primarily used to treat fluid overload (edema).
INDICATIONS AND USAGE — Edema: “LASIX is indicated… for the treatment of edema associated with congestive heart failure, cirrhosis of the liver, and renal disease…” (Section 1)
Fluid overload (edema) treated with furosemide injection can be caused by heart failure.
INDICATIONS AND USAGE — Edema: “edema associated with congestive heart failure…” (Section 1)
Fluid overload (edema) treated with furosemide injection can be caused by liver disease.
INDICATIONS AND USAGE — Edema: “edema associated with… cirrhosis of the liver…” (Section 1)
Fluid overload (edema) treated with furosemide injection can be caused by kidney disease.
INDICATIONS AND USAGE — Edema: “edema associated with… renal disease…” (Section 1)
Furosemide injection works by helping the body eliminate excess salt and water through the urine.
Elimination of excess salt and water through the urine reduces swelling.
Reducing swelling eases the workload on the heart.
Furosemide injection is administered by a healthcare professional.
Unsupported Statements
The price of furosemide injection can vary based on dosage, quantity, and manufacturer.
No pricing/market information is present in the provided FDA label excerpts.
Furosemide injection is a generic medication.
Generic status is not stated in the provided label excerpts.
Generic drugs generally lead to lower costs compared to branded drugs.
No economic comparison language is present in the provided label excerpts.
Prices for a single vial or pre-filled syringe of furosemide injection can range from approximately $3 to $15.
No pricing figures are present in the provided FDA label excerpts.
Multi-dose vials or larger quantities may offer a lower per-unit cost.
No pricing/pack-size economics are present in the provided label excerpts.
A pack of 10 vials might be priced between $20 and $80.
No pricing figures are present in the provided FDA label excerpts.
Furosemide injection is available through pharmacies.
No distribution/dispensing channel availability is present in the provided label excerpts.
Pharmacies may require a prescription from a healthcare provider to dispense furosemide injection.
No dispensing status language is present in the provided label excerpts.
Hospitals and clinics administer furosemide injection directly to patients during medical treatments.
No administration setting language is present in the provided label excerpts.
Wholesale distributors and medical supply companies provide furosemide injection to healthcare providers.
No wholesaler/supply chain language is present in the provided label excerpts.
Most health insurance plans cover furosemide injection.
No insurance coverage statements are present in the provided label excerpts.
Furosemide injection is manufactured by multiple pharmaceutical companies.
No manufacturer enumeration language is present in the provided label excerpts.
As a generic drug, the active ingredient and therapeutic effect of furosemide injection are the same across manufacturers.
No generics-manufacturer equivalence statements are present in the provided label excerpts.
There might be minor differences in inactive ingredients or formulations between manufacturers of furosemide injection.
No inactive-ingredient/formulation comparison language is present in the provided label excerpts.
Differences in formulations between manufacturers can sometimes lead to slight variations in price.
No pricing relationship language is present in the provided label excerpts.
Higher milligram strengths of furosemide injection may be priced differently than lower ones.
No pricing by strength language is present in the provided label excerpts.
Purchasing furosemide injection in bulk often results in a lower per-unit cost.
No bulk-purchase economics language is present in the provided label excerpts.
Pharmacy markup increases the final cost of furosemide injection.
No markup language is present in the provided label excerpts.
Furosemide injection prices can differ geographically due to local market conditions and distribution costs.
No geographic pricing language is present in the provided label excerpts.
The price of furosemide injection might vary if purchased through a hospital pharmacy versus a retail pharmacy.
No channel-specific pricing language is present in the provided label excerpts.
Furosemide injection is primarily used to treat fluid overload (edema).
Partially supported as edema is an indication, but the term “primarily used” is not explicitly stated in the provided excerpts.
Furosemide injection is typically administered intravenously (IV).
The provided excerpts do not state typical route for the injection.
Furosemide injection is typically administered intramuscularly (IM).
The provided excerpts do not state typical route for the injection.
The route of administration and dosage of furosemide injection depend on the patient's condition and the urgency of treatment.
The provided excerpts discuss dose adjustment/titration and individualized needs, but do not explicitly mention “urgency” or route dependence for injection.
Contradictions
Low
AI Statement
Furosemide injection is typically administered intramuscularly (IM).
Label Reference
No contradiction can be established from provided excerpts.
Important Omissions
For safety-related claims, the label emphasizes that excessive dosing can cause profound diuresis with water/electrolyte depletion and requires careful medical supervision; the AI response did not include this labeled warning content.
Importance:
Moderate
Contraindication: anuria and hypersensitivity to furosemide are explicitly listed in the label; the AI response did not mention these contraindications.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Info
Most claims are non-label factual statements (pricing/coverage/distribution) that are not directly safety-relevant per the provided excerpts. However, the response omits label-required safety elements such as contraindications and key warning/monitoring themes, which could reduce safe interpretation.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Mostly Unaligned
Primary Issue
Large portions of the AI response are not supported by the supplied FDA label excerpts (especially pricing, insurance/coverage, and route-of-administration assertions).
Suggested Improvement
Limit claims to content present in the FDA prescribing information excerpts provided (e.g., labeled indications for edema; labeled contraindication in anuria/hypersensitivity; labeled warning about excessive dosing causing water/electrolyte depletion; labeled monitoring for fluid/electrolyte imbalance and labs). Avoid specific pricing and distribution/coverage statements unless the label text explicitly supports them.